Live Breaking News & Updates on Semin Arthritis

Stay updated with breaking news from Semin arthritis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Headache, Migraine Burden Significant in Psoriatic Arthritis, Axial Spondyloarthritis

Headache prevalence was significantly higher in the PsA and axSpA cohorts compared with healthy controls. ....

United States , Annalisa Marino , Matteo Vistocco Unsplash , University Of Rome , Health Assessment Questionnaire , World Health Organization , Leeds Enthesitis Index , Psoriatic Arthritis , Axial Spondyloarthritis , Italian Cohort , Semin Arthritis , American Migraine Study ,

In Rheumatic Disease, Cardiovascular Risk is Greatest within First Year of Diagnosis

A Finnish study finds elevated cardiovascular risk in rheumatic diseases peaks within a year of diagnosis, emphasizing the need for early management strategies. ....

Drug Administration , Turku University , Tampere University Hospital , Semin Arthritis , Cardiovascular Disease , Ra And Cvd ,

Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting

− The Study Met Its Primary Endpoint with 53.3% and 54.2% of Patients Treated With TAK-279 Achieving At Least an ACR 20 Response Compared to 29.2% in the Placebo Group at Week 12 1

− TAK-279. ....

United States , San Diego , New Orleans , United Kingdom , Alan Kivitz , Greenwood Carriero , Exchange Commission , Research Development , Health Technology Assessment , Journals Library , American College Of Rheumatology , American Academy Of Dermatology Annual Meeting , Takeda Pharmaceutical Company Limited , Arthritis Foundation , Society For Investigative Dermatology Annual Meeting , Takeda Pharmaceuticals , American College , Psoriasis Area , Severity Index , Physician Global Assessment , Andy Plump , Psoriatic Arthritis , Tyrosine Kinase , Annual Report , Dermatology Annual , Investigative Dermatology Annual ,

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis

− Topline Results for TAK-279 Show that a Significantly Greater Proportion of Psoriatic Arthritis Patients Achieved at Least an ACR20 Response Compared to Placebo at Week 121

− Based on the. ....

United States , New Orleans , Greenwood Carriero , American Academy Of Dermatology Annual Meeting , Society For Investigative Dermatology Annual Meeting , Takeda Pharmaceutical Company Limited , Exchange Commission , Takeda Pharmaceuticals , American College Of Rheumatology , American College , Andy Plump , Fiscal Year , Psoriasis Area , Severity Index , Tyrosine Kinase , Annual Report , Semin Arthritis , Dermatology Annual , Investigative Dermatology Annual , Subjects With Active Psoriatic , Immune Mediated Inflammatory ,

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK279 a Highly Selective Oral TYK2 Inhibitor for the Treatment of Active Psoriatic Arthritis

Takeda TSE4502NYSETAK today announced positive topline results from its randomized doubleblind placebocontrolled multipledose Phase 2b trial evaluating TAK279 an investigational oral allosteric tyrosine kinase 2 TYK2 inhibitor with next generation selectivity in people with active psoriatic arthritis. ....

New Orleans , United States , Mark Dole , Jun Saito , Greenwood Carriero , Takeda Pharmaceuticals , Exchange Commission , American College Of Rheumatology , Takeda Pharmaceutical Company Limited , International Media , American Academy Of Dermatology Annual Meeting , Society For Investigative Dermatology Annual Meeting , Topline Results , Significantly Greater Proportion , Psoriatic Arthritis Patients Achieved , Positive Results , Takeda Intends , Full Clinical Results Will , Upcoming Medical , American College , Andy Plump , Fiscal Year , Psoriasis Area , Severity Index , Tyrosine Kinase , Annual Report ,